Page 2090 - Williams Hematology ( PDFDrive )

2064 Part XII: Hemostasis and Thrombosis Chapter 120: Hereditary Qualitative Platelet Disorders 2065

138. Lee H, Nurden AT, Thomaidis A, Caen JP: Relationship between fibrinogen binding 169. Simon DI, Chen Z, Xu H, et al: Platelet glycoprotein Ibα is a counterreceptor for the
and platelet glycoprotein deficiencies in Glanzmann’s thrombasthenia type I and type II. leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 192:193–204, 2000.
Br J Haematol 48:47, 1981. 170. Bradford HN, Dela Cadena RA, Kunapuli SP, et al: Human kininogens regulate
139. Coller BS, Seligsohn U, Peretz H, Newman PJ: Glanzmann thrombasthenia: New thrombin binding to platelets through the glycoprotein Ib-IX-V complex. Blood
insights from an historical perspective. Semin Hematol 31:301–311, 1994. 90:1508–1515, 1997.
140. Shattil SJ, Hoxie JA, Cunningham M, Brass LF: Changes in the platelet membrane gly- 171. Jurk K, Clemetson KJ, de Groot PG, et al: Thrombospondin-1 mediates platelet adhe-
coprotein IIb.IIIa complex during platelet activation. J Biol Chem 260:11107–11114, sion at high shear via glycoprotein Ib (GPIb): An alternative/backup mechanism to von
1985. Willebrand factor. FASEB J 17:1490–1492, 2003.
141. Karpatkin M, Howard L, Karpatkin S: Studies of the origin of platelet-associated fibrin- 172. Baglia FA, Badellino KO, Li CQ, et al: Factor XI binding to the platelet glycopro-
ogen. J Lab Clin Med 104:223–237, 1984. tein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem 277:
142. Grimaldi CM, Chen F, Scudder LE, et al: A Cys374Tyr homozygous mutation of platelet 1662–1668, 2002.
glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann’s thrombasthenia. Blood 173. Bradford HN, Pixley RA, Colman RW: Human factor XII binding to the glycopro-
88:1666–1675, 1996. tein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem
143. Yasunaga K, Nomura S: Statistical analysis of Glanzmann’s thrombasthenia in Japan. 275:22756–22763, 2000.
Acta Haematol 89:165–166, 1993. 174. Ware J, Russell S, Ruggeri ZM: Generation and rescue of a murine model of platelet
144. Kashiwagi H, Kunishima S, Kiyomizu K, et al: Demonstration of novel gain-of- dysfunction: The Bernard-Soulier syndrome. Proc Natl Acad Sci U S A 97:2803–2808,
function mutations of alphaIIbbeta3: Association with macrothrombocytopenia and 2000.
Glanzmann thrombasthenia-like phenotype. Mol Genet Genomic Med 1:77–86, 2013. 175. Kato K, Martinez C, Russell S, et al: Genetic deletion of mouse platelet glycoprotein
145. Kunishima S, Kashiwagi H, Otsu M, et al: Heterozygous ITGA2B R995W mutation Ibbeta produces a Bernard-Soulier phenotype with increased alpha-granule size. Blood
inducing constitutive activation of the alphaIIbbeta3 receptor affects proplatelet forma- 104:2339–2344, 2004.
tion and causes congenital macrothrombocytopenia. Blood 117:5479–5484, 2011. 176. Ramakrishnan V, Reeves PS, DeGuzman F, et al: Increased thrombin responsiveness in
146. Ghevaert C, Salsmann A, Watkins NA, et al: A nonsynonymous SNP in the ITGB3 gene platelets from mice lacking glycoprotein V. Proc Natl Acad Sci U S A 96:13336–13341,
disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIb- 1999.
beta3 integrin and cosegregates dominantly with abnormal proplatelet formation and 177. Nonne C, Hechler B, Cazenave JP, et al: Reassessment of in vivo thrombus formation
macrothrombocytopenia. Blood 111:3407–3414, 2008. in glycoprotein V deficient mice backcrossed on a C57Bl/6 strain. J Thromb Haemost
147. Nurden AT, Pillois X, Fiore M, et al: Glanzmann thrombasthenia-like syndromes 6:210–212, 2008.
associated with Macrothrombocytopenias and mutations in the genes encoding the 178. Grottum KA, Solum NO: Congenital thrombocytopenia with giant platelets: A defect
alphaIIbbeta3 integrin. Semin Thromb Hemost 37:698–706, 2011. in the platelet membrane. Br J Haematol 16:277–290, 1969.
148. Schaffner-Reckinger E, Salsmann A, Debili N, et al: Overexpression of the partially acti- 179. Greenberg JP, Packham MA, Guccione MA, et al: Survival of rabbit-platelets treated in
vated alpha(IIb)beta3D723H integrin salt bridge mutant downregulates RhoA activity vitro with chymotrypsin, plasmin, trypsin, and neuraminidase. Blood 53:916–927, 1979.
and induces microtubule-dependent proplatelet-like extensions in Chinese hamster 180. Heyns Ad, Badenhorst PN, Wessels P, et al: Kinetics, in vivo redistribution and sites of
ovary cells. J Thromb Haemost 7:1207–1217, 2009. sequestration of indium-111-labelled platelets in giant platelet syndromes. Br J Haematol
149. Jayo A, Conde I, Lastres P, et al: L718P mutation in the membrane-proximal cytoplas- 60:323–330, 1985.
mic tail of beta 3 promotes abnormal alpha IIb beta 3 clustering and lipid microdomain 181. Tomer A, Scharf RE, McMillan R, et al: Bernard-Soulier syndrome: Quantitative char-
coalescence, and associates with a thrombasthenia-like phenotype. Haematologica acterization of megakaryocytes and platelets by flow cytometric and platelet kinetic
95:1158–1166, 2010. measurements. Eur J Haematol 52:193–200, 1994.
150. Peyruchaud O, Nurden AT, Milet S, et al: R to Q amino acid substitution in the GFFKR 182. Nurden P, Nurden A: Giant platelets, megakaryocytes and the expression of glycopro-
sequence of the cytoplasmic domain of the integrin IIb subunit in a patient with a tein Ib- IX complexes. C R Acad Sci III 319:717–726, 1996.
Glanzmann’s thrombasthenia-like syndrome. Blood 92:4178–4187, 1998. 183. Vettore S, Scandellari R, Scapin M, et al: A case of Bernard-Soulier Syndrome due to
151. Hughes PE, Diaz-Gonzalez F, Leong L, et al: Breaking the integrin hinge. A defined a homozygous four bases deletion (TGAG) of GPIbalpha gene: Lack of GPIbalpha but
structural constraint regulates integrin signaling. J Biol Chem 271:6571–6574, 1996. absence of bleeding. Platelets 19:388–391, 2008.
152. Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC: Bernard-Soulier syndrome. 184. George JN, Nurden AT: Inherited disorders of the platelet membrane: Glanzmann’s
Blood 91:4397–4418, 1998. thrombasthenia and Bernard-Soulier syndrome, in Hemostasis and Thrombosis:
153. Lopez JA, Berndt MC: The GPIb-IX-V complex, in Platelets, edited by AD Michelson, Basic Principles and Clinical Practice, edited by RW Colman, J Hirsh, VJ Marder, EW
p. 85. Academic Press, San Diego, 2002. Salzman, p 726. Lippincott, Philadelphia, 1987.
154. Savoia A, Kunishima S, De Rocco D, et al: Spectrum of the mutations in Bernard- 185. Ruggeri Z: The platelet glycoprotein Ib-IX complex. Prog Hemost Thromb 10:35–68,
Soulier syndrome. Hum Mutat 35:1033–1045, 2014. 1991.
155. Andrews RK, Berndt MC: Bernard-Soulier syndrome: An update. Semin Thromb 186. Andrews RK, Lopez JA, Berndt MC: The GPIb-IX-V complex, in Platelets, 3rd ed,
Hemost 39:656–662, 2013. edited by AD Michelson. Academic Press, San Diego, 2013.
156. Bernard J, Soulier JP: Sur une nouvelle variete de dystrophie thrombocytaire- 187. Roth GJ: Developing relationships: Arterial platelet adhesion, glycoprotein Ib, and
hemorragipare congenitale. Semin Hop Paris. 24:3217, 1948. leucine-rich glycoproteins. Blood 77:5–19, 1991.
157. Bernard J: History of congenital hemorrhagic thrombocytopathic dystrophy. Blood 188. Yap CL, Hughan SC, Cranmer SL, et al: Synergistic adhesive interactions and signaling
Cells 9:179, 1983. mechanisms operating between platelet glycoprotein Ib/IX and integrin alpha IIbbeta 3.
158. Weiss HJ, Tschopp TB, Baumgartner HR, et al: Decreased adhesion of giant Studies in human platelets ans transfected Chinese hamster ovary cells. J Biol Chem
(Bernard-Soulier) platelets to subendothelium. Further implications on the role of the 275:41377–41388, 2000.
von Willebrand factor in hemostasis. Am J Med 57:920–925, 1974. 189. Gardiner EE, Arthur JF, Shen Y, et al: GPIbalpha-selective activation of platelets
159. Howard MA, Hutton RA, Hardisty RM: Hereditary giant platelet syndrome: A disorder induces platelet signaling events comparable to GPVI activation events. Platelets
of a new aspect of platelet function. Br Med J 2:586–588, 1973. 21:244–252, 2010.
160. Bithell TC, Parekh SJ, Strong RR: Platelet-function studies in the Bernard-Soulier 190. Zhou YF, Eng ET, Zhu J, et al: Sequence and structure relationships within von
syndrome. Ann N Y Acad Sci 201:145–160, 1972. Willebrand factor. Blood 120:449–458, 2012.
161. Nurden AT, Caen JP: Specific roles for platelet surface glycoproteins in platelet 191. Wu YP, Vink T, Schiphorst M, et al: Platelet thrombus formation on collagen at high
function. Nature 255:720–722, 1975. shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhib-
162. Howard MA, Perkin J, Salem HH, Firkin BG: The agglutination of human platelets by ited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Arterioscler Thromb
botrocetin: Evidence that botrocetin and ristocetin act at different sites on the factor VIII Vasc Biol 20:1661–1667, 2000.
molecule and platelet membrane. Br J Haematol 57:25–35, 1984. 192. Kulkarni S, Dopheide SM, Yap CL, et al: A revised model of platelet aggregation. J Clin
163. Moake JL, Olson JD, Troll JH, et al: Binding of radioiodinated human von Willebrand Invest 105:783–791, 2000.
factor to Bernard- Soulier, thrombasthenic and von Willebrand’s disease platelets. 193. Matsui H, Sugimoto M, Mizuno T, et al: Distinct and concerted functions of von
Thromb Res 19:21–27, 1980. Willebrand factor and fibrinogen in mural thrombus growth under high shear flow.
164. Zucker MB, Kim SJ, McPherson J, Grant RA: Binding of factor VIII to platelets in the Blood 100:3604–3610, 2002.
presence of ristocetin. Br J Haematol 35:535–549, 1977. 194. Ikeda Y, Handa M, Kawano K, et al: The role of von Willebrand factor and fibrinogen in
165. Berndt MC, Gregory C, Chong BH, et al: Additional glycoprotein defects in Bernard- platelet aggregation under varying shear stress. J Clin Invest 87:1234–1240, 1991.
Soulier’s syndrome: Confirmation of genetic basis by parental analysis. Blood 62: 195. Peterson DM, Stathopoulos NA, Giorgio TD, et al: Shear-induced platelet aggregation
800–807, 1983. requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa.
166. Clemetson KJ, McGregor JL, James E, et al: Characterization of the platelet membrane Blood 69:625–628, 1987.
glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal 196. Ruggeri ZM: Mechanisms of shear-induced platelet adhesion and aggregation. Thromb
by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. Haemost 70:119, 1993.
J Clin Invest 70:304–311, 1982. 197. Jamieson GA, Okumura T: Reduced thrombin binding and aggregation in Bernard-
167. Vanhoorelbeke K, Ulrichts H, Romijn RA, et al: The GPIbalpha-thrombin interaction: Soulier platelets. J Clin Invest 61:861–864, 1978.
Far from crystal clear. Trends Mol Med 10:33–39, 2004. 198. Jandrot-Perrus M, Rendu F, Caen JP, et al: The common pathway for alpha- and
168. Romo GM, Dong JF, Schade AJ, et al: The glycoprotein Ib-IX-V complex is a platelet gamma-thrombin-induced platelet activation is independent of GPIb: A study of
counterreceptor for P-selectin. J Exp Med 190:803–814, 1999. Bernard-Soulier platelets. Br J Haematol 75:385–392, 1990.

Kaushansky_chapter 120_p2039-2072.indd 2065 9/21/15 2:22 PM